Citation Impact
Citing Papers
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
1997
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Infective Endocarditis
2005 Standout
Vancomycin Use in a University Medical Center: Comparison With Hospital Infection Control Practices Advisory Committee Guidelines
1996
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Current Treatment Options for Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfection
2008
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
1996
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Emerging and Re-emerging Infectious Diseases
2000
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
2002
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
1999
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1996
Synthetic biology
2005
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
An Outbreak of Community-Onset Methicillin-ResistantStaphylococcus aureusSkin Infections in Southwestern Alaska
2003
Nasal Carriage as a Source ofStaphylococcus aureusBacteremia
2001 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Community-acquired methicillin-resistant Staphylococcus aureus infections
2006
Staphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies
2004
Cigarette Smoking and Invasive Pneumococcal Disease
2000
Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
2012
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
2003 Standout
Human ehrlichiosis: Hematopathology and immunohistologic detection of Ehrlichia chaffeensis
1993
Community-associated meticillin-resistant Staphylococcus aureus
2010
Methicillin‐resistant staphylococci
1990
Ehrlichia ewingii,a Newly Recognized Agent of Human Ehrlichiosis
1999
Changing patterns of mortality across Europe in patients infected with HIV-1
1998
Community‐Associated Methicillin‐Resistant Staphylococcus aureus: A Review
2004
Grade 4 Events Are as Important as AIDS Events in the Era of HAART
2003
CHAT Oral Polio Vaccine Was Not the Source of Human Immunodeficiency Virus Type 1 Group M for Humans
2001
The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling Model
2007
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
2006
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Trimethoprim-Sulfamethoxazole for the Prevention of Methicillin-Resistant Staphylococcus aureus Pneumonia in Severely Burned Patients
1998
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Methicillin-Resistant Staphylococcus aureus
1989 Standout
Management of Methicillin‐ResistantStaphylococcus aureusBacteremia
2008
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
2008
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
2005
Direct Cultivation of the Causative Agent of Human Granulocytic Ehrlichiosis
1996
Foundations for engineering biology
2005 StandoutNature
Ticks and Tickborne Bacterial Diseases in Humans: An Emerging Infectious Threat
2001 Standout
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
Use of Long-Acting Tetracyclines for Methicillin-Resistant Staphylococcus aureus Infections: Case Series and Review of the Literature
2005
Combinatorial infection andin vivorecombination: a strategy for making large phage antibody repertoires
1993 StandoutNobel
Bacteremic Pneumonia Due to Staphylococcus aureus: A Comparison of Disease Caused by Methicillin-Resistant and Methicillin-Susceptible Organisms
1999
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery
1992
Considerations in choice of a clinical endpoint for AIDS clinical trials
1994
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
2020 StandoutNature
Delayed infection, family size and malignant lymphomas
2000
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Human ehrlichioses
2002
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
Ehrlichial Diseases of Humans: Emerging Tick-Borne Infections
1995
The Pathophysiology and Treatment of Sepsis
2003 Standout
Sex differences in HIV-1 viral load and progression to AIDS
1998
Zika Virus and Birth Defects — Reviewing the Evidence for Causality
2016 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Changing Virus‐Host Interactions in the Course of HIV‐1 Infection
1994
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
The CD4 lymphocyte count and risk of clinical progression
2006
Herpes Zoster
2013 Standout
Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities
1997
Staphylococcus aureusInfections
1998 Standout
Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients
2003
Skin and Soft-Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureus
2007
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Serologic evidence for human ehrlichiosis in Africa
1994
Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infections in Children
2006
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Staphylococcus aureus
1984
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease
1994 Standout
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
2007
Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
1993
Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Vertebral Osteomyelitis Cases Complicated by Bacteremia Treated with High-Dose Daptomycin and Trimethoprim-Sulfamethoxazole
2012
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis
2009
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
EMERGING AND RESURGING VECTOR-BORNE DISEASES
1999
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus
1984
Coagulase-Negative Staphylococci
1989
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus
1995
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
1996
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark.
1999
Staphylococcus aureus Bacteremia
2003
Anti-inflammatory therapies to treat sepsis and septic shock
1997
Human Ehrlichioses: Newly Recognized Infections Transmitted by Ticks
1998
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
1997
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The tribe Ehrlichieae and ehrlichial diseases
1991
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
1997 Standout
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group
1994
Nosocomial Infections with Methicillin and Tobramycin Resistant Staphylococcus aureus—Implication of Physiotherapy in Hospital-Wide Dissemination
1985
Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus Infections
2004
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates
1996
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis
1992
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
The Crisis in Antibiotic Resistance
1992 StandoutScience
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome
1995
Climate Warming and Disease Risks for Terrestrial and Marine Biota
2002 StandoutScience
Treatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory Clinic
2006
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction
1992
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis
1991
Methicillin-resistant staphylococci
1988
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Human disease in Europe caused by a granulocytic Ehrlichia species
1997
Rickettsioses as paradigms of new or emerging infectious diseases
1997
Molecular Analyses of Oral Polio Vaccine Samples
2001 StandoutScienceNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Methicillin‐resistant Staphylococcus aureus in the Australian community: an evolving epidemic
2006
Emergence of the Ehrlichioses as Human Health Problems
1996
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis
1991
Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
1996
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii
1992
STAPHYLOCOCCUS AUREUS BACTEREMIA AND ENDOCARDITIS
1993
Clinical Management ofStaphylococcus aureusBacteremia
2014
Human anti-self antibodies with high specificity from phage display libraries.
1993
Works of Norman Markowitz being referenced
A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection
1994
Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency Virus
1995
Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter
1996
Patterns of HIV-1 and HTLV-I/II in Intravenous Drug Abusers from the Middle Atlantic and Central Regions of the USA
1990
Cancer Incidence among an HIV-infected Cohort
1997
Clinical Safety, Tolerability, and Pharmacokinetics of Murine Monoclonal Antibody to Human Tumor Necrosis Factor-
1994
Rapid Decrease in Unintegrated Human Immunodeficiency Virus DNA after the Initiation of Nucleoside Therapy
1994
The role of tumor necrosis factor in sepsis
1992
Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection
1992
Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow
2004
Randomized, Open-Label Study of the Impact of Two Doses of Subcutaneous Recombinant Interleukin-2 on Viral Burden in Patients With HIV-1 Infection and CD4+ Cell Counts of ≥300/mm3: CPCRA 059
2002
Incidence of Tuberculosis in the United States among HIV-Infected Persons
1997
Human Infection withEhrlichia canis, a Leukocytic Rickettsia
1987
Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections
1986
Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons
1993
In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981
1983
Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia
1996